J. Nucl. Me. 2020 Aug 17
18F-PSMA-1007-PET/CT reliably detects malignant lymph nodes and has an exceptional specificity of >99% for nodal metastases. Congratulations for this international investigation led by PositronMed, University of Heildelberg Germany and Osaka University Japan. A great diagnostics advances for an adequate treatment of prostate cancer.
Read more >>
Other news & events
- News04.12.2025

#BlueNovemberWithRadiotheranostics for Urologists, Oncologists and Nuclear Medicine physicians
Read more - News10.11.2025

#BlueNovemberWithRadiotheranostics - The VISION trial: Meet Dr Alison Armour
Read more - News06.11.2025

Oncidium Foundation USA Achieves 501(c)(3) Status to Expand Patient Access to Nuclear Medicine and Theranostics
Read more




